French | English

Home : R&D > Projects

Development product portfolio

BioAlliance Pharma places intellectual property at the heart of its activities and develops a proactive “Intellectual Property” strategy that is directly linked to its research and development projects.

At the end of 2008, the product portfolio is protected by 29 families of published patents, including 231 patent applications and patents of which over 50% have been issued.